Updated from 5:59 a.m. EDT
If you'd like to receive "5 Things" in your email inbox every morning, please register for TheStreet Alerts and follow me.
Here are five things you must know for Friday, Nov. 4:
1. -- U.S. stock futures pointed to a lower open for Wall Street on Friday ahead of the monthly U.S. jobs report and as the S&P 500 has declined for eight straight sessions, due in part to uncertainty over next week's presidential election.
The economic calendar in the U.S. on Friday includes the U.S. nonfarm payrolls report for October at 8:30 a.m. EDT. Economists surveyed by FactSet expect the U.S. to have added 171,500 jobs last month with the unemployment rate dipping to 4.9% from 5.0% in September.
Many economists believe a strong jobs report could seal the deal for an interest rate hike from the Federal Reserve when it meets again December.
Also on the docket is the Trade Balance for September at 8:30 a.m.
Humana (HUM) , which agreed to be acquired by Aetna AET, posted third-quater adjusted earnings of $3.18 a share, 3 cents above forecast. The health insurer also trimmed its earnings guidance for 2016.
The stock was inactive in premarket trading.
The stock rose 1.5% in premarket trading on Friday.
Starbucks said overall same-store sales in the quarter rose 4% for the second straight three-month period, and came in below Wall Street estimates for a 4.8% increase. Prior to the third quarter, Starbucks had notched an impressive 25-quarter stretch of 5% or more same-store sales growth.
Net sales rose 16% from the prior year to $5.71 billion, surpassing analysts' forecasts for $5.69 billion. Earnings were 56 cents a share, narrowly surpassing estimates of 55 cents.
CEO Howard Schulz cited uncertainty about next week's U.S. presidential election and the popularity of online shopping as he spoke to investors on a conference call.
"I would label this time as one with a high degree of uncertainty -- domestically driven -- but it has affected the rest of the world. Where we have visited, we have never witnessed such concern as a result of the (U.S. presidential) election," Schultz told analysts.
Schultz, who endorsed presidential hopeful Hillary Clinton in September, added, "It's very hard to cut through the noise and get our message to the consumer."
The DOJ's investigation has been under way for at least two years and a number of companies have reported receiving subpoenas related to the investigation.
Shares of Mylan (MYL) fell 7% on Thursday and other companies thought subject to the investigation were hit too. The stock was up 1% in premarket trading on Friday.
Shares of Allergan (AGN) , which disclosed in 2015 that it had received a subpoena from the DOJ, dropped 4.58%. Allergan announced at the time that the DOJ was "seeking information relating to the marketing and pricing of certain of the Company's generic products and communications with competitors about such products."
"The news is another destructive hit to the pharma group that had been riddled with skepticism thanks to the election and rhetoric over price-gouging. Now with the generics in play, investors are again painting the entire sector with one brush, giving no company the benefit of the doubt," Cramer said.